"phase 2" trang 4 - tải miễn phí từ tailieunhanh
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial
8    80    1
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
13    35    1
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial
9    59    1
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma
8    49    1
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouraciloxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: The PROTECT-1402, randomized phase 2 trial

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouraciloxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: The PROTECT-1402, randomized phase 2 trial
7    93    1
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: A study protocol

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: A study protocol
5    82    1
Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor

Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor
9    75    1
Malignancy in giant cell tumor of bone: Analysis of an open-label phase 2 study of denosumab

Malignancy in giant cell tumor of bone: Analysis of an open-label phase 2 study of denosumab
12    38    1
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study
8    32    1
Spatial organization of endometrial gene expression at the onset of embryo attachment in pigs

Spatial organization of endometrial gene expression at the onset of embryo attachment in pigs
19    16    1
Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: A phase 2, multi-center, randomized, prospective, interventional trial

Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: A phase 2, multi-center, randomized, prospective, interventional trial
8    29    1
Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics

Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics
8    30    1
Lecture ECE 6450 Microelectronic - Chapter 2: Semiconductor substrates

Lecture ECE 6450 Microelectronic - Chapter 2: Semiconductor substrates
14    61    3
Lecture Power system operation and control - Lesson 2: Introduction, Power grid history

Lecture Power system operation and control - Lesson 2: Introduction, Power grid history
38    38    1
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: A randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: A randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
11    17    1
Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: A single-arm, phase 2 study

Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: A single-arm, phase 2 study
8    20    1
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)
8    16    1
Ebook Thermodynamics in material (Second Edition): Part 2

Ebook Thermodynamics in material (Second Edition): Part 2
343    37    1
Overview and outcomes of the OECD/NEA benchmark study of the accident at the Fukushima Daiichi NPS (BSAF), Phase 2 – Results of severe accident analyses for unit 3

Overview and outcomes of the OECD/NEA benchmark study of the accident at the Fukushima Daiichi NPS (BSAF), Phase 2 – Results of severe accident analyses for unit 3
12    12    1
Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial?

Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial?
8    1    1